Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-12

Clinical Trial Update: Risk Factors for Carbapenem-resistant Acinetobacter Baumannii

View source ↗

Summary

Completed clinical trial investigating risk factors for carbapenem-resistant Acinetobacter baumannii infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Acinetobacter Infections | Status: COMPLETED